Securities code: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) securities abbreviation: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Announcement No.: 2022021 bond Code: 113585 bond abbreviation: Shouxian convertible bond
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
Report on the use of previously raised funds
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
In accordance with the provisions on the report on the use of previously raised funds (zjfz [2007] No. 500) issued by the China Securities Regulatory Commission, the report on the use of previously raised funds of the company as of December 31, 2021 is as follows:
1、 Basic information of previously raised funds
(I) actual amount of raised funds and availability of funds
1. Availability of funds raised by initial public offering
Approved by the China Securities Regulatory Commission in the reply on the approval of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) initial public offering of shares (zjxk [2017] No. 520), the lead underwriter Guosen Securities Co.Ltd(002736) issued 34.95 million RMB ordinary shares (A shares) by combining offline inquiry and placement with online capital purchase and pricing issuance, with an issue price of 11.54 yuan / share.
As of May 4, 2017, the company has actually issued 34.95 million RMB ordinary shares (A shares) to the public, and the total amount of funds raised is 40332300000 yuan. The funds raised after deducting the total issuance cost of 451 Shanghai Pudong Development Bank Co.Ltd(600000) 0 yuan is 35816300000 yuan. It has been remitted from Guosen Securities Co.Ltd(002736) to the company on May 4, 2017 and opened in the special account of Bank Of China Limited(601988) Wuyi County sub branch with account No. 357172714656, totaling 37332300000 yuan (after deducting underwriting and recommendation fees of 3000000000 yuan), deducting other external expenses directly related to the issuance of equity securities of 151 Shanghai Pudong Development Bank Co.Ltd(600000) 0 yuan, and the net amount of raised funds is 35816300000 yuan.
The above funds have been verified by Lixin Certified Public Accountants (special general partnership) and issued the capital verification report (xksbz [2017] No. zf10516) in May 2017. The company has adopted a special account storage system for the raised funds.
2. Availability of funds raised by public issuance of convertible corporate bonds
Approved by the reply on approving Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) public issuance of convertible corporate bonds (zjxk [2020] No. 658) of China Securities Regulatory Commission, the company has publicly issued 360 million yuan of convertible corporate bonds, with a face value of 100 yuan each, a total of 3 Shanghai Pudong Development Bank Co.Ltd(600000) , with a term of 6 years. After deducting the issuance expenses paid by the company for the convertible corporate bonds, the net amount of funds actually raised was 34915566038 yuan.
All the above-mentioned raised funds have been put in place on June 15, 2020 and deposited in the special account for raised funds for management. Lixin Certified Public Accountants (special general partnership) has verified the receipt of raised funds and issued the capital verification report on the paid in subscription funds (xksbz [2020] No. zf10574). The company adopts a special account storage system for the raised funds and has established relevant special accounts for the raised funds. After the raised funds are received, they have been deposited in the special account for the raised funds, and a supervision agreement has been signed with the sponsor and the bank storing the raised funds. (II) storage of raised funds in special account
1. Storage of funds raised from initial public offering in special account
As of December 31, 2021, the balance of the special account for the deposit of raised funds is as follows:
Unit: RMB
Name of raised fund storage bank bank account account nature initial deposit amount ending balance
Bank Of China Limited(601988) Wuyi County sub branch 357172714656 account closed 37332300000-
China Citic Bank Corporation Limited(601998) Hangzhou branch 8110801014001106117 account closed —
Industrial And Commercial Bank Of China Limited(601398) Wuyi sub branch 120806 Harbin Medisan Pharmaceutical Co.Ltd(002900) 0458732 closed account —
China Merchants Bank Co.Ltd(600036) Jinhua Branch 579900719110902 closed account —
China Citic Bank Corporation Limited(601998) Hangzhou branch 8110801013101141208 closed account —
Total — 37332300000-
2. Storage of funds raised by public issuance of convertible corporate bonds in the special account
As of December 31, 2021, the balance of the special account for the deposit of raised funds is as follows:
Unit: RMB
Name of raised fund storage bank bank account account nature initial deposit amount ending balance
Special for non budget units of China China Construction Bank Corporation(601939) Co., Ltd
Company Wuyi sub branch 330501677327 Shenzhen China Bicycle Company (Holdings) Limited(000017) 45 deposit account 350990 Shenzhen Fountain Corporation(000005) 18462
Special for non budget units of China Industrial And Commercial Bank Of China Limited(601398) Co., Ltd
Company Wuyi sub branch 120806 Harbin Medisan Pharmaceutical Co.Ltd(002900) 0515117 deposit account – 19 Jiangmen Kanhoo Industry Co.Ltd(300340) 04
Bank Of China Limited(601988) special for non budget companies
Wuyi sub branch 388378066721 deposit account – 965164777
Total 350900 China Vanke Co.Ltd(000002) 895717243
2、 Actual use of the previously raised funds
(I) comparison table of the use of the previously raised funds
See attached table 1 of this report for the comparison table of the use of funds raised by the company’s initial public offering.
The comparison table of the use of the funds raised by the company’s public issuance of convertible bonds is detailed in Schedule 2 of this report.
(II) changes in the actual investment projects of the previously raised funds
The company has no changes in the actual investment projects of the previously raised funds.
(III) external transfer or replacement of investment projects with previously raised funds
The company has no external transfer or replacement of the investment projects of the previously raised funds.
(IV) use of temporarily idle raised funds
1. Supplement working capital with temporarily idle funds
The company does not use temporarily idle funds to supplement working capital.
2. Use temporarily idle funds for cash management and investment in related products
(1) Cash management of funds raised from initial public offering and investment in related products
As of December 31, 2021, the funds raised from the initial public offering of shares have been used up, and there is no use of temporarily idle raised funds for cash management.
(2) On June 22, 2020, the 15th meeting of the third board of directors of the company considered and adopted the proposal on using some temporarily idle raised funds for cash management, The board of directors of the company agrees to use the temporarily idle raised funds with a total amount of no more than 410 million yuan (including the amount of 100 million yuan deliberated and approved at the 12th meeting of the third board of directors) for cash management, with a service life of no more than 12 months. The resolution is valid for one year from the date of deliberation and approval, and can be recycled and used within the validity period of the above amount and resolution.
On April 27, 2021, the 23rd Meeting of the third board of directors and the 18th meeting of the third board of supervisors respectively deliberated and approved the proposal on using some temporarily idle raised funds and self owned funds for cash management, and agreed that the company would use no more than 400 million yuan of temporarily idle raised funds and no more than 500 million yuan of temporarily idle self owned funds to buy financial products with high safety, good liquidity and low risk, The service life shall not exceed 12 months, and the resolution shall be valid within 12 months from the date of deliberation and adoption. Within the validity period of the above quota and resolution, it can be recycled and used.
As of December 31, 2021, the balance of financial products purchased by the company with temporarily idle raised funds is RMB 100 million, as follows:
Unit: RMB
Expected annualized actual arrival on the date of entrustment termination
Name of entrusted party entrusted amount entrusted starting date closing balance period yield financial management income
Industrial And Commercial Bank Of China Limited(601398) Wuyi sub branch 20000 China Vanke Co.Ltd(000002) 021 / 12 / 172022 / 1 / 18 1.05-3.09% not due 2000000000
Industrial And Commercial Bank Of China Limited(601398) Wuyi sub branch 80000 China Vanke Co.Ltd(000002) 021 / 12 / 172022 / 1 / 18 1.05-3.09% not due 8000000000
As of December 31, 2021, the balance of time deposits purchased by the company with temporarily idle raised funds is RMB 164 million, as follows:
Unit: RMB
Expected annualized actual arrival
Name of entrusted party entrusted amount entrusted start date entrusted end date ending balance rate of return financial management income
Zhejiang Mintai Commercial Bank Co., Ltd
1400000000 at any time on March 12, 2021, 3.50% of the outstanding 1400000000 Jinhua Wuyi small and micro enterprise franchise sub branch Zhejiang Mintai Commercial Bank Co., Ltd
2000000000 on August 2, 2021, you can withdraw 3.50% of the unexpired 2000000000 Jinhua Wuyi small and micro enterprise franchise sub branch, Wuyi sub branch of Jinhua Bank Co., Ltd
70000 China Vanke Co.Ltd(000002) 021 / 8 / 2 2022 / 2 / 2 3.80% unexpired 7000000000 business department Jinhua Bank Co., Ltd. Wuyi sub branch
